Cargando…

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models

The environmentally friendly design of analytical methods is gaining interest in pharmaceutical analysis to reduce hazardous environmental impacts and improve safety and health conditions for analysts. The adaptation and integration of chemometrics in the development of environmentally friendly anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Mohamed S., Abdelazim, Ahmed H., Ramzy, Sherif, Batubara, Afnan S., Gamal, Mohammed, Abdelhafiz, Safwan, Zeid, Abdallah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373238/
https://www.ncbi.nlm.nih.gov/pubmed/37501208
http://dx.doi.org/10.1186/s13065-023-01001-5
_version_ 1785078523586674688
author Imam, Mohamed S.
Abdelazim, Ahmed H.
Ramzy, Sherif
Batubara, Afnan S.
Gamal, Mohammed
Abdelhafiz, Safwan
Zeid, Abdallah M.
author_facet Imam, Mohamed S.
Abdelazim, Ahmed H.
Ramzy, Sherif
Batubara, Afnan S.
Gamal, Mohammed
Abdelhafiz, Safwan
Zeid, Abdallah M.
author_sort Imam, Mohamed S.
collection PubMed
description The environmentally friendly design of analytical methods is gaining interest in pharmaceutical analysis to reduce hazardous environmental impacts and improve safety and health conditions for analysts. The adaptation and integration of chemometrics in the development of environmentally friendly analytical methods is strongly recommended in the hope of promising benefits. Favipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of this work is to develop green, tuned spectrophotometric methods based on chemometric based models for the determination of favipiravir and remdesivir in spiked human plasma. The UV absorption spectra of favipiravir and remdesivir has shown overlap to some extent, making simultaneous determination difficult. Three advanced chemometric models, classical least squares, principal component regression, and partial least squares, have been developed to provide resolution and spectrophotometric determination of the drugs under study. A five-level, two-factor experimental design has been used to create the described models. The spectrally recorded data of favipiravir and remdesivir has been reviewed. The noise region has been neglected as it has a negative impact on the significant data. On the other hand, the other spectral data provided relevant information about the investigated drugs. A comprehensive evaluation and interpretation of the results of the described models and a statistical comparison with accepted values have been considered. The proposed models have been successfully applied to the spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form spiked human plasma. In addition, the environmental friendliness of the described models was evaluated using the analytical eco-scale, the green analytical procedure index and the AGREE evaluation method. The results showed the compliance of the described models with the environmental characteristics.
format Online
Article
Text
id pubmed-10373238
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-103732382023-07-28 Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models Imam, Mohamed S. Abdelazim, Ahmed H. Ramzy, Sherif Batubara, Afnan S. Gamal, Mohammed Abdelhafiz, Safwan Zeid, Abdallah M. BMC Chem Research The environmentally friendly design of analytical methods is gaining interest in pharmaceutical analysis to reduce hazardous environmental impacts and improve safety and health conditions for analysts. The adaptation and integration of chemometrics in the development of environmentally friendly analytical methods is strongly recommended in the hope of promising benefits. Favipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of this work is to develop green, tuned spectrophotometric methods based on chemometric based models for the determination of favipiravir and remdesivir in spiked human plasma. The UV absorption spectra of favipiravir and remdesivir has shown overlap to some extent, making simultaneous determination difficult. Three advanced chemometric models, classical least squares, principal component regression, and partial least squares, have been developed to provide resolution and spectrophotometric determination of the drugs under study. A five-level, two-factor experimental design has been used to create the described models. The spectrally recorded data of favipiravir and remdesivir has been reviewed. The noise region has been neglected as it has a negative impact on the significant data. On the other hand, the other spectral data provided relevant information about the investigated drugs. A comprehensive evaluation and interpretation of the results of the described models and a statistical comparison with accepted values have been considered. The proposed models have been successfully applied to the spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form spiked human plasma. In addition, the environmental friendliness of the described models was evaluated using the analytical eco-scale, the green analytical procedure index and the AGREE evaluation method. The results showed the compliance of the described models with the environmental characteristics. Springer International Publishing 2023-07-27 /pmc/articles/PMC10373238/ /pubmed/37501208 http://dx.doi.org/10.1186/s13065-023-01001-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Imam, Mohamed S.
Abdelazim, Ahmed H.
Ramzy, Sherif
Batubara, Afnan S.
Gamal, Mohammed
Abdelhafiz, Safwan
Zeid, Abdallah M.
Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title_full Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title_fullStr Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title_full_unstemmed Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title_short Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
title_sort adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373238/
https://www.ncbi.nlm.nih.gov/pubmed/37501208
http://dx.doi.org/10.1186/s13065-023-01001-5
work_keys_str_mv AT imammohameds adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT abdelazimahmedh adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT ramzysherif adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT batubaraafnans adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT gamalmohammed adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT abdelhafizsafwan adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels
AT zeidabdallahm adjustedgreenspectrophotometricdeterminationoffavipiravirandremdesivirinpharmaceuticalformandspikedhumanplasmasampleusingdifferentchemometricsupportedmodels